357 related articles for article (PubMed ID: 19049806)
1. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
2. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats.
Eddahibi S; Adnot S; Frisdal E; Levame M; Hamon M; Raffestin B
J Pharmacol Exp Ther; 2001 Apr; 297(1):148-54. PubMed ID: 11259539
[TBL] [Abstract][Full Text] [Related]
3. [Atorvastatin attenuates hypoxic pulmonary hypertension in rats by inhibiting RhoA/Rho kinase pathway].
Dai L; Wu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 36(1):58-63. PubMed ID: 21311140
[TBL] [Abstract][Full Text] [Related]
4. Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Rochefort GY; Lemaire MC; Eder V; Hanton G; Hyvelin JM; Bonnet P; Antier D
Eur J Pharmacol; 2006 Nov; 550(1-3):149-54. PubMed ID: 17026993
[TBL] [Abstract][Full Text] [Related]
5. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
[TBL] [Abstract][Full Text] [Related]
6. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
Li FH; Xia W; Sun RP
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
Zhang Y; Dai L; Wu S; Chen P; Zhao S
Chin Med J (Engl); 2014; 127(5):869-72. PubMed ID: 24571879
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery.
Sauzeau V; Rolli-Derkinderen M; Lehoux S; Loirand G; Pacaud P
Circ Res; 2003 Oct; 93(7):630-7. PubMed ID: 12946946
[TBL] [Abstract][Full Text] [Related]
11. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
12. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
14. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
[TBL] [Abstract][Full Text] [Related]
16. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
[TBL] [Abstract][Full Text] [Related]
18. [Research on Rho-kinase expression in pulmonary arterioles of rat exposed to hypoxia].
Yang L; Cheng DY; Chen XJ; Su OL; Xia XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):395-8. PubMed ID: 16761417
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia.
Eddahibi S; Raffestin B; Launay JM; Sitbon M; Adnot S
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1111-9. PubMed ID: 9563727
[TBL] [Abstract][Full Text] [Related]
20. Maxingxiongting mixture attenuates hypoxia pulmonary arterial hypertension to improve right ventricular hypertrophy by inhibiting the rho-kinase signaling pathway.
An X; Li S; Weng X; Wang X; Wu H; Zhang X; Gao J; Yang R; Peng B; Li S; Weng X; Wang X; Zhang X; Gao J
J Tradit Chin Med; 2020 Dec; 40(6):992-998. PubMed ID: 33258351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
